This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Bavarian Nordic A/s. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Stephanie Sanos
Introduction
Stephanie Sanos is a prominent inventor based in Munich, Germany. She has made significant strides in the field of immunology, particularly through her innovative research and development of immunogenic compositions. Her work has the potential to impact the way diseases are treated and prevented.
Latest Patents
Stephanie Sanos holds a patent for "Methods and compositions for intra-nasal immunization with recombinant MVA encoding flagellin." This patent describes immunogenic compositions that include a recombinant modified vaccinia virus Ankara (MVA) containing a nucleic acid sequence encoding a flagellin, along with a sequence for a heterologous disease-associated antigen. The compositions are designed to induce enhanced T-cell and antibody-mediated immune responses specific to the disease-associated antigen when administered to subjects, such as humans.
Career Highlights
Sanos is currently associated with Bavarian Nordic A/S, a company known for its focus on developing innovative vaccines. Her work at Bavarian Nordic has allowed her to contribute to groundbreaking research in the field of immunization.
Collaborations
Some of her notable coworkers include Henning Lauterbach and Hubertus Hochrein, who have collaborated with her on various projects within the company.
Conclusion
Stephanie Sanos is a trailblazer in the field of immunology, with her patent and work at Bavarian Nordic A/S showcasing her commitment to advancing medical science. Her contributions are paving the way for new approaches to disease prevention and treatment.